SEC Form 4 · accession 0001190725-16-000300
Mirati Therapeutics, Inc. · MRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Isan Chen
Officer — Sr.Vice President, Chief Medi
Period of report
Jan 13, 2016
Accepted (ET)
Jan 15, 2016 · 3:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001576263
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 13, 2016 | M | 2,542 | $15.79 | A | 18,113 | D | |
| Common Stock | holding | — | — | — | 110 | I | By Chen Living Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $15.79 | Jan 13, 2016 | M | 2,542 | D | — | Nov 7, 2023 | Common Stock | 2,542 | 106,792 | D |
Explanation of responses
- F1(1)1/4th of the shares subject to the Option shall vest and become exercisable on September 1, 2014, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested